NEVVI Medicare utilization intelligence
or

← back

Provider profile

HOWELL, MARY MD

Internal Medicine · NPI 1821058710 · HAGERSTOWN, MD

1
Groups
19
Codes · 2024
74,489
Disclosed services

HOWELL, MARY is a Internal Medicine in HAGERSTOWN, MD, a member of 1 medical group, who billed 19 distinct codes to Medicare Part B in 2024.

Groups: MERITUS MEDICAL CENTER INC (HAGERSTOWN, MD)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

74,489
disclosed services
19
codes billed to Medicare Part B
Prior year · CY2023 127,546 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J3111 Injection, romosozumab-aqqg, 1 mg
J0897 Injection, denosumab, 1 mg
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1010 Injection, methylprednisolone acetate, 1 mg
J1745 Injection, infliximab, excludes biosimilar, 10 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96372 Injection of drug or substance under skin or into muscle
36415 Insertion of needle into vein for collection of blood sample
77085 Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
96413 Administration of chemotherapy into vein, 1 hour or less
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance
20610 Aspiration and/or injection of fluid from large joint
J1030 Injection, methylprednisolone acetate, 40 mg
20600 Aspiration and/or injection of fluid from small joint

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.